Related Experiment Video
Updated: Sep 12, 2025
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
Published on: May 31, 2024
Pouch surgery for ulcerative colitis in 2025: A narrative review
Andrea Vignali1, Pierpaolo Sileri1
1Department of Colorectal Surgery, San Raffaele Scientific Institute, Vita e salute University Milan, Italy.
Background:
Restorative proctocolectomy with ileoanal pouch is the standard procedure in ulcerative colitis patients with medical refractory disease, dysplasia or in selected patients with Crohn's disease. The advent of biologics has reduced the rate of elective colectomies, the timing of surgery and the type of the surgical approach and increased the stages of the operation.
Aim:
to analyze the main chances in pouch surgery with a focus on staging, minimally invasive surgery and trans anal approach.
Results:
the decision on the staging approach should be individualized according to disease severity, preoperative nutritional status, intraoperative variables and preoperative exposure to immunomodulators. A minimally invasive approach is recommended when feasible. Trans-anal ileal pouch is a promising technically demanding operation, subject to procedure specific risk and should be performed only by experienced surgeons.
Conclusion:
The minimally invasive approaches are evolving, but large-scale controlled studies are needed to confirm their efficacy and safety.
More Related Videos
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...